Stay updated on Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial
Sign up to get notified when there's something new on the Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial page.

Latest updates to the Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial page
- Check2 days agoNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new revision entry v3.7.0 was added to the Record History, and the previous revision v3.6.6 was removed from the list. This reflects an update to the visible version history of the study record.SummaryDifference0.1%

- Check36 days agoChange DetectedA new revision entry v3.6.6 has been added to the study record history, and the previous revision v3.6.5 has been removed from the list. This reflects an update to the page's version history rather than changes to the study details.SummaryDifference0.1%

- Check57 days agoChange DetectedThe record history now includes a new revision entry (v3.6.5) that supersedes the previous revision (v3.6.4). This indicates a minor update to the study record without altering the substantive content.SummaryDifference0.1%

- Check72 days agoChange DetectedA new Revision: v3.6.4 entry was added to the record history. The previous Revision: v3.6.3 entry appears to have been removed from the log, signaling an update to the page’s versioning.SummaryDifference0.1%

- Check93 days agoChange DetectedA new revision tag 'Revision: v3.6.3' was added and the previous 'Revision: v3.6.2' was removed in the page history. This reflects a minor update to the page's revision metadata rather than any changes to the study content.SummaryDifference0.1%

- Check100 days agoChange DetectedA new revision entry v3.6.2 was added to the record history and an older revision v3.6.0 was removed, updating the page's version history to reflect the latest administrative update.SummaryDifference0.1%

Stay in the know with updates to Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial page.